✦ LIBER ✦

Lung cancer screening results in the National Cancer Institute New York Study

✍ Scribed by Myron R. Melamed

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 127 KB
Volume: 89
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20001201)89:11+<2356::aid-cncr8>3.0.co;2-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The prostate, lung, colorectal, and ovar

The prostate, lung, colorectal, and ovarian cancer screening trial of the national cancer institute

✍ John K. Gohagan; Philip C. Prorok; Barnett S. Kramer; Richard B. Hayes; Joyce E. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB 👁 2 views

The two-year pilot phase of the Prostate, Lung, Colorectal, and Ovarian (PLCO) trial concluded September 29, 1994. The goals, organization, operation, and recruitment status of the trial are discussed. The PLCO trial is a 16year randomized controlled screening trial involving 148,000 male and female

Nation-wide breast cancer screening in T

Nation-wide breast cancer screening in The Netherlands: Results of initial and subsequent screening 1990–1995

✍ Jacques Fracheboud; Harry J. de Koning; Petra M. M. Beemsterboer; Rob Boer; Jan 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 52 KB 👁 2 views

Based on an extensive cost-effectiveness analysis, the Dutch nation-wide breast cancer screening programme started in 1990, providing a biennial screen examination to women aged 50 to 69 years. The programme is monitored by the National Evaluation Team, which annually collects tabulated regional eva

A case–control study for evaluating the

A case–control study for evaluating the efficacy of mass screening program for lung cancer in miyagi prefecture, Japan

✍ Motoyasu Sagawa; Yoshitaka Tsubono; Yasuki Saito; Masami Sato; Ichiro Tsuji; Sat 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Phase II study of pemetrexed disodium, a

Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma : A study of the national cancer institute of Canada clinical trials group

✍ Frances A. Shepherd; Janet Dancey; Andrew Arnold; Alan Neville; James Rusthoven; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

## Background: Pemetrexed disodium (alimta [eli lilly and company, indianapolis, in], ly231514, multitargeted antifolate) is a new multitargeted antifolate agent that inhibits multiple enzymes in the folate pathway. phase ii trials showed single-agent response rates of 16% and 23% in untreated pati

Cancer prevention and screening in light

Cancer prevention and screening in light of health promotion and prevention of disability for the second 50 years. A report from the institute of medicine of the national academy of science

✍ Robert L. Berg 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 2 views

The impact of genetic variation in DRD2

The impact of genetic variation in DRD2 and SLC6A3 on smoking cessation in a cohort of participants 1 year after enrollment in a lung cancer screening study

✍ Mindi A. Styn; Tomoko Nukui; Marjorie Romkes; Kenneth Perkins; Stephanie R. Land 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 3 views

## Abstract Smoking cessation strategies continue to have disappointing results. By determining the interindividual genetic differences that influence smoking behaviors, we may be able to develop tailored strategies that increase the likelihood of successful cessation. This study attempts to determ